Lung cancer trials in Italy

In Italy 272 Also abroad 2746

272 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
Where
Catanzaro
Age
18 years and over
People
10,000
Run by
University Magna Graecia
See details and how to joinNCT05681962
No phaseTaking people
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
Where
Milan, Rome, Rozzano
Age
18 years and over
People
472
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06737107
No phaseTaking people
Cognitive Screening in Lung Cancer Patients
Where
Milan
Age
18 years to 70 years
People
200
Run by
European Institute of Oncology
See details and how to joinNCT06727370
No phaseTaking people
Prevention of Smoking Related Diseases
Where
Milan
Age
50 years and over
People
189
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06451029
No phaseTaking people
The Lymphocytic Infiltrate of Lung Tumors.
Where
Milan
Age
18 years and over
People
70
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06470607
No phaseTaking people
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Where
Milan, Rome, Rozzano
Age
18 years and over
People
140 worldwide
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06626243
No phaseTaking people
Robotic Assisted Major Lung Resection in Elderly Patients
Where
Milan, Rozzano
Age
18 years and over
People
386
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06496386
Phase 2Not yet taking people in Italy
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)
Where
Milan, Pavia
Age
18 years and over
People
27
Run by
Fondazione Centro Nazionale Di Adroterapia Oncologica
See details and how to joinNCT05229614 · EU 2024-517378-22-00
Phase 2Not yet taking people in Italy
A Phase II, open label, single arm, multicentre study on THOracic Radiotherapy in Extensive Stage SCLC patients submitted to first line CHT-RT plus Durvalumab (MEDI4736)
Where
Brescia, Florence, Genoa, Modena, Negrar, Padova, Parma, Pavia, Reggio Emilia, Trento
Age
18 years and over
People
94
Run by
Azienda Ospedaliero Universitaria Di Modena
See details and how to join2024-517445-13-00
No phaseTaking people
PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
Where
Naples
Age
18 years to 80 years
People
25
Run by
National Cancer Institute, Naples
See details and how to joinNCT04854213
No phaseTaking people
Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
Where
Milan
Age
18 years and over
People
2,840
Run by
Scientific Institute San Raffaele
See details and how to joinNCT06626178
No phaseTaking people
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Where
Milan
Age
18 years and over
People
270
Run by
European Institute of Oncology
See details and how to joinNCT05974475
No phaseTaking people
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)
Where
Aviano
People
700
Run by
Centro di Riferimento Oncologico - Aviano
See details and how to joinNCT06180005
Phase 2Taking people
A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
Where
Naples
Age
18 years and over
People
35
Run by
National Cancer Institute, Naples
See details and how to joinNCT04893785
Phase 2Taking people
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
Where
Aviano, Florence, Lido di Camaiore, Meldola, Monza, Padova, Parma, Perugia, Udine
Age
18 years and over
People
45
Run by
Centro di Riferimento Oncologico - Aviano
See details and how to joinNCT06378892
No phaseTaking people
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Where
Genova, Messina, Rome, Turin
Age
18 years to 70 years
People
70
Run by
A.O.U. Città della Salute e della Scienza
See details and how to joinNCT05689619
No phaseTaking people
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Where
Milan
Age
18 years and over
People
1,200
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05550961
No phaseEnrolling by invitation
Italian Lung Cancer Observational Study
Where
L’Aquila
Age
18 years and over
People
1,000
Run by
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
See details and how to joinNCT05851755
No phaseTaking people
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer
Where
Rome
Age
18 years and over
People
100
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05797493
No phaseWithdrawn
Establishment of a Tumor Bank for Blood Samples
Where
Milan
Age
18 years and over
People
10,000 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT01763125
Phase 2Not yet taking people in Italy
FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
Where
Milan
Age
18 years to 75 years
People
20
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05703997
Phase 2Not yet taking people in Italy
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome
Where
Verona
Age
18 years to 75 years
People
105
Run by
Universita di Verona
See details and how to joinNCT05597800